Microarray-based gene expression analysis of F4/80+ cells isolated from the peripheral blood of control, 4 T1-bearing and anti-angiogenic drug treated 4 T1-bearing mice is ongoing with the purpose to identify relevant genes associated with tumor Eltanexor datasheet growth or angiogenesis. These results
will be validated in human peripheral blood cells collected from healthy volunteers, and cancer patients before, during and after anti-angiogenic therapies. O131 Intravital Imaging of Human Prostate Cancer Using Bombesin-Targeted Viral Nanoparticles Amber Ablack1, Nicole Steinmetz3, Jennifer L. Hickey2, Jailal Ablack1, Leonard Luyt2, Marianne Manchester3, John D. Lewis 1 1 Department of Oncology, University of Western Ontario, London, ON, Canada, 2 Department of Chemistry, University of Western Ontario, London, ON, Canada, 3 Department of Cell Biology, Center for Integrative Biosciences, The Scripps Research Institute, La Jolla, CA, USA Viral nanoparticles
offer an attractive multivalent platform for diagnostic in vivo imaging of prostate and other cancers. We have developed a nanoparticle platform based on the cowpea mosaic virus (CPMV) that offers discrete control over the conjugation of detection moieties, solubilization polymers PD0332991 concentration and targeting ligands to the viral capsid. We report here the specific targeting and imaging of human PC-3 prostate cancer cells in vitro and in vivo with PEGylated fluorescent viral nanoparticles conjugated to a pan-LY2109761 mouse bombesin peptide. The amphibian tetradecapeptide, bombesin, selectively interacts with the gastrin-releasing peptide (GRP) receptor family that is over-expressed on human prostate cancer cells. Bombesin peptide was
conjugated to CPMV particles functionalized with a near-infrared (NIR) dye (Alexa Fluor 647) and polyethylene glycol (PEG) using the copper(I)-catalyzed azide-alkyne Selleckchem Forskolin cycloaddition reaction. Absorbance measurements indicated that each nanoparticle contained 90 NIR dyes and 80–95 PEG or bombesin-PEG units. The integrity of CPMV particles was verified by FPLC, SDS PAGE and transmission electron microscopy. The bombesin-targeted CPMV particles showed a marked increase in uptake by PC-3 cells compared to a non-targeted control as measured by flow cytometry, and specificity was confirmed by successful blocking with an excess of soluble bombesin peptide. Targeting of PC-3 cells in vitro was confirmed by confocal microscopy. Bombesin conjugated CPMV showed impressive targeting and uptake in human prostate tumors in vivo, using a shell-less avian embryo tumor model. Taken together, we have shown here that bombesin-targeted viral nanoparticles offer a highly selective imaging tool for human prostate tumors, using a platform with future potential for clinical non-invasive imaging strategies and drug delivery.